The overall efficacy of the AstraZeneca/Oxford vaccine was 70.42%, while Bharat Biotech's COVAXIN was "safe and provides a robust immune response", Drugs Controller General of India V.G. "Vaccines of M/s Serum and M/s Bharat Biotech are being approved for restricted use in emergency situations," Somani read out from a written statement at a press conference. Sources told Reuters on Saturday the doses would have to be given four weeks apart. "It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India!" "COVISHIELD, India's first COVID-19 vaccine, is approved, safe, effective and ready to roll-out in the coming weeks."

Source: bd News24 January 03, 2021 06:33 UTC